000 03789nam a22003615i 4500
999 _c393271
_d393271
001 393271
003 ES-MaUEC
005 20231210224737.0
006 a|||| o|||| 00| 0
007 cr nn 008mamaa
008 100301s2000 xxu| s |||| 0|eng d
020 _a9781592590421
024 7 _a10.1385/159259042X
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aQP552 .N38
_b2000 EB
245 0 0 _aNeuropeptide Y Protocols
_cedited by Ambikaipakan Balasubramaniam
250 _a1st edition 2000
264 1 _aTotowa, NJ
_bHumana Press
_c2000
300 _a1 recurso en línea (X, 246 páginas)
_b52 ilustraciones, 3 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aMethods in Molecular Biology
_x1940-6029
_v153
505 0 _aCloning Techniques -- Cloning Neuropeptide Tyrosine cDNA -- Human Y1/Y5 Receptor Gene Cluster -- Human Type 2 Neuropeptide Y Receptor Gene -- Y4 Receptor in Different Species -- NeuropeptideYY5 Receptor Expression -- Homology-Based Cloning Methods -- Production of Transgenic and Knock-Out Models -- Developing Transgenic NeuropeptideY Rats -- NeuropeptideYY1 Receptor-Deficient Mice -- Antisense Technology -- Antisense Oligonucleotide Approach to Study NPY-Mediated Feeding Signal Transduction -- A G?i RNA-Antisense Expression Strategy to Investigate Coupling of Peptide YY/Neuropeptide Y Receptor to G?i -- NPY Y5 Receptor Subtype -- NPY Antisense Oligodeoxynucleotides to Study the Actions of NPY -- Techniques to Study Tissue Distribution of mRNA -- Localization of Y-Receptor Subtype mRNAs in Rat Brain by Digoxigenin Labeled In Situ Hybridization -- Central Y4 Receptor Distribution -- Combining Non-Isotopic Localization of NPY mRNA with Immunocytochemistry -- Miscellaneous Techniques -- Y Receptors Characterized by RT-PCR -- Quantification of NPY mRNA by Ribonuclease Protection Assay -- Radioligand Binding Studies.
520 _aIt is now clear that neuropeptide Y (NPY), the most abundant peptide present in the mammalian nervous system, is implicated in the pathophysiology of many diseases, including eating disorders, seizures, memory loss, anxiety, depression, and cardiovascular diseases, and offers major therapeutic opportunities for their treatment. In Neuropeptide Y Protocols, a strong cohort of established investigators from a variety of disciplines detail their best techniques for advancing NPY research. Among the many readily reproducible methods described are those for cloning, for the production of transgenic and knockout models, and for the use of antisense technology to define the receptors and the signal transduction pathways mediating NPY actions. A range of the major qualitative and quantitative techniques used to study tissue mRNA distribution are also included, as well as methods for radioligand binding. The cloning techniques utilize genomic DNA isolation, expression cloning, PCR cloning, the construction of hybrid receptors, and homology-based cloning. Highly practical and state-of-the-art, Neuropeptide Y Protocols constitutes a gold-standard collection of proven techniques for advancing today's understanding of this significant neuropeptide, as well as for developing the promising NPY-based therapeutics now emerging for many important disorders.
988 _aSpringer_Protocols_2000
650 7 _2embne
_9502304
_aNeuropéptidos
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1385/159259042X
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b12/2023
_dz
_ejc
_zSI